NasdaqGM:TMDXMedical Equipment
TransMedics Expands OCS Program As Kidney And Lung Platform Story Grows
TransMedics Group expanded its National Organ Care System Program, aiming to handle a larger share of U.S. transplant procedures.
The company is advancing kidney and lung transplant initiatives, including full control of the ENHANCE clinical trial.
TransMedics is preparing simultaneous U.S. and Europe clinical trial launches for its kidney program as part of a broader transplant platform push.
TransMedics Group, NasdaqGM:TMDX, is pushing beyond its medical device roots toward a more...